4DMEDICAL
Company

Last deal

$13.6M
Local Amount - AUD 20M

Amount

Post-IPO Equity

Stage

08.05.2023

Date

1

all rounds

$13.6M

Total amount

General

About Company
4DMedical is a global medical technology company that revolutionizes respiratory imaging and ventilation analysis for lung diseases.

Industry

Sector :

Subsector :

Keywords :

Also Known As

4Dx

founded date

01.01.2012

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

The company's mission is to improve global health by providing unique and non-invasive imaging technologies that enable unprecedented insight into pulmonary functioning, critical in the analysis and management of respiratory diseases. 4DMedical commercializes its patented imaging platform, XV Technology, which uses mathematical models and algorithms to convert X-ray scans into quantitative data that helps physicians manage patients with respiratory diseases and diseases of the lung. The company generates revenue from the sale of hardware products and XV Technology software.